These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11337359)

  • 1. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi.
    Rosen ED; Raymond S; Zollman A; Noria F; Sandoval-Cooper M; Shulman A; Merz JL; Castellino FJ
    Am J Pathol; 2001 May; 158(5):1613-22. PubMed ID: 11337359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
    Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
    Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
    Collen D; Lu HR; Stassen JM; Vreys I; Yasuda T; Bunting S; Gold HK
    Thromb Haemost; 1994 Jan; 71(1):95-102. PubMed ID: 8165652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis.
    Kleinschnitz C; Braeuninger S; Pham M; Austinat M; Nölte I; Renné T; Nieswandt B; Bendszus M; Stoll G
    Stroke; 2008 Apr; 39(4):1262-8. PubMed ID: 18292385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
    Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA
    J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice.
    Kramkowski K; Leszczynska A; Przyborowski K; Proniewski B; Marcinczyk N; Rykaczewska U; Jarmoc D; Chabielska E; Chlopicki S
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):85-94. PubMed ID: 27743016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
    Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
    Goto S; Tamura N; Ishida H
    J Am Coll Cardiol; 2004 Jul; 44(2):316-23. PubMed ID: 15261925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
    André P; LaRocca T; Delaney SM; Lin PH; Vincent D; Sinha U; Conley PB; Phillips DR
    Circulation; 2003 Nov; 108(21):2697-703. PubMed ID: 14597584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.
    Dubois C; Panicot-Dubois L; Gainor JF; Furie BC; Furie B
    J Clin Invest; 2007 Apr; 117(4):953-60. PubMed ID: 17380206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
    Sim DS; Dilks JR; Flaumenhaft R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse.
    Maurice P; Pires V; Amant C; Kauskot A; Da Nascimento S; Sonnet P; Rochette J; Legrand C; Fauvel-Lafeve F; Bonnefoy A
    Vascul Pharmacol; 2006 Jan; 44(1):42-9. PubMed ID: 16269270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
    Weichert W; Pauliks V; Breddin HK
    Haemostasis; 1983; 13(1):61-71. PubMed ID: 6132858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PAF-acether antagonist (N 48740 RP/Rhône-Poulenc) and laser-induced thrombi in rat mesenteric vessels.
    Weichert W; Breddin HK
    Haemostasis; 1989; 19(4):229-34. PubMed ID: 2807041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.